ANTHRA PHARMACEUTICALS INC S-1
Accession 0000950123-98-002443
Filed
Mar 10, 7:00 PM ET
Accepted
—
Size
1.2 MB
Accession
0000950123-98-002443
Documents
- S-1Primary
FORM S-1
- EX-1
UNDERWRITTING AGREEMENT BETWEEN THE REPRESENTATIVE
- EX-3.1
AMENDED & RESTATED CERTIFICATE OF INCORPORATION
- EX-3.2
BYLAWS OF THE COMPANY
- EX-4.3
5TH AMENDED & RESTATED REGISTARTION RIGHTS,OCTOBER
- EX-10.1
AGREEMENT DATED NOVEMBER 6, 1990
- EX-10.2
AGREEMENT BETWEEN MICHAEL C. WALKER
- EX-10.3
AGREEMENT BETWEEN MERVYN ISRAEL
- EX-10.4
EXCLUSIVE SUPPLY AGREEMENT DATED JUNE 1,1991
- EX-10.5
TERMINATION,SETTLEMENT,INVESTMENT AGREEMENT
- EX-10.6
AGREEMENT BETWEEN ALLEN L. THUNBERG
- EX-10.7
AGREEMENT BETWEEN MICHAEL C. WALKER
- EX-10.8
AGREEMENT DATED NOVEMBER 27, 1998
- EX-10.9
EXCLUSIVE LICENSE AGREEMENT DATED APRIL 17, 1997
- EX-10.10
SUBLEASE DATED JULY 2,1997
- EX-10.11
DEVELOPMENT AGREEMENT DATED JULY 15, 1997
- EX-10.12
SUPPLY AGREEMENT DATED SEPTEMBER 11,1997
- EX-10.13
1990 STOCK PLAN AS AMENDED
- EX-10.14
LICENSE,SALE AND DISTRIBUTION AGREEMENT
- EX-10.15
TERM SHEET DATED DECEMBER 12, 1997
- EX-10.16
UNDERLEASE OF SUITE B DATED DECEMBER 27, 1997
- EX-11
PRO FORMA LOSS PER SHARE COMPUTATION
- EX-21
SUBSIDIARY
- EX-23
CONSENT OF KPMG PEAT MARWICK LLP
- EX-27
SUMMARY FINANCIAL DATA SCHEDULE
Issuer
ANTHRA PHARMACEUTICALS INC
CIK 0001054839
Related Parties
1- filerCIK 0001054839
Filing Metadata
- Form type
- S-1
- Filed
- Mar 10, 7:00 PM ET
- Size
- 1.2 MB